In a mouse model, it was reported that the use of galantamine, an acetylcholinesterase inhibitor in mice with diet-induced obesity, decreases the inflammatory status and reduces bodyweight and fatty liver [67]. The gene discussed is ACHE; the disease is obesity disorder.